Neurocrine(CH:NB3)
CH:NB3
Neurocrine earnings date
Neurocrine (NB3) Q2 2026 Earnings Report
0 Followers
CH:NB3 Q2 2026 EPS Results
- Actual EPS
- CHF 1.17
- Consensus EPS
- CHF 1.38
- Beat/Miss
- Missed by -CHF 0.22
- One Year Ago EPS
- CHF 0.89
CH:NB3 Q2 2026 Revenue Results
- Actual Revenue
- CHF 804.73M
- Expected Revenue
- CHF 747.80M
- Beat/Miss
- Beat by +CHF 56.93M
- YoY Revenue Growth
- +39.49%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/30/2026
- Time
- After Close
- Conference Call
- Thursday, July 30, 2026
CH:NB3 Upcoming Earnings
Neurocrine's next earnings date is estimated for February 11, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
CH:NB3 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:NB3 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 11, 2027 | 2026 (Q4) | 1.74- | 1.24 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 1.601.64 | 1.71 | -3.92% (-0.07) | |
| Jul 30, 2026 | 2026 (Q2) | 1.381.17 | 0.89 | 31.13% (+0.28) | |
| May 05, 2026 | 2026 (Q1) | 1.021.60 | 0.07 | 2287.50% (+1.54) | |
| Feb 11, 2026 | 2025 (Q4) | 1.511.24 | 0.84 | 48.00% (+0.40) | |
| Oct 28, 2025 | 2025 (Q3) | 1.341.71 | 1.04 | 64.52% (+0.67) | |
| Jul 30, 2025 | 2025 (Q2) | 0.810.89 | 0.53 | 68.25% (+0.36) | |
| May 05, 2025 | 2025 (Q1) | 0.450.07 | 0.35 | -80.95% (-0.29) | |
| Feb 06, 2025 | 2024 (Q4) | 1.350.84 | 1.21 | -30.56% (-0.37) | |
| Oct 30, 2024 | 2024 (Q3) | 1.251.04 | 0.69 | 51.22% (+0.35) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


